SCHEMBL25664265

SCHEMBL25664265

Cc1cccc(CNC2=Nc3cccc(C(=O)N(C)C)c3NC23CCOCC3)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 5/20 0.39
▸ CYP2C19 P33261 5/20 0.39
▸ ALDH1A1 P00352 5/20 0.39
▸ HPGD P15428 5/20 0.39
▸ HSD17B10 Q99714 5/20 0.39
▸ CYP3A4 P08684 4/20 0.39
▸ TSHR P16473 3/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ LMNA P02545 3/20 0.38
▸ CYP2D6 P10635 2/20 0.38
▸ MAPT P10636 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ PIK3CB P42338 2/20 0.37
▸ USP2 O75604 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ ALOX12 P18054 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17758068 0.90 PIK3CB (0.37) CYP2C19CYP3A4PIK3CBCYP2C9RPS6KB1
SCHEMBL17757618 0.81 CYP3A4 (0.38) CYP2C19CYP3A4MAPK1CYP2C9RPS6KB1
SCHEMBL17757560 0.80 CD38 (0.36) MAPK1RPS6KB1CXCR2
SCHEMBL17757770 0.80 ACAT2 (0.39) RPS6KB1CXCR2
SCHEMBL17757044 0.80 PDE2A (0.38) CYP1A2CYP2C19ALDH1A1HPGDHSD17B10
SCHEMBL17757812 0.80 PIK3CB (0.37) PIK3CBRPS6KB1PIK3CA
SCHEMBL19523217 0.79 PIK3CB (0.40) CYP1A2CYP2C19ALDH1A1HPGDHSD17B10
SCHEMBL17757819 0.79 PIK3CB (0.36) CYP2C19CYP3A4MAPK1PIK3CBCYP2C9
SCHEMBL17758064 0.79 PIK3CB (0.37) LMNAPIK3CBPIK3CA
SCHEMBL17758041 0.78 CD38 (0.43) PIK3CBAURKARPS6KB1PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3021847-B1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM GESUNDHEIT & UMWELT GMBH (DE) 2023-06-07 — — EP disclosed
Send feedback